Chapter 14 References
1. Rowe NG, Mitchell PG, Cumming RG, Wans JJ. Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiology 2000; 7: 103–14.
2. Stein JD, Grossman DS, Mundy KM, Sugar A, Sloan FA. Severe adverse events after cataract surgery among medicare beneficiaries. Ophthalmology 2011; 118: 1716–23.
3. Tan JS, Wang JJ, Mitchell P. Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains eye study. Ophthalmic Epidemiology 2008; 15: 317–27.
4. Greenberg PB, Tseng VL, Wu WC, et al. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology 2011; 118: 507–14.
5. Raman R, Pal SS, Adams JS, Rani PK, Vaitheeswaran K, Sharma T. Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, report no. 17. Investigative Ophthalmology & Visual Science 2010; 51: 6253–61.
6. Hauser D, Katz H, Pokroy R, Bukelman A, Shechtman E, Pollack A. Occurrence and progression of diabetic retinopathy after phacoemulsification cataract surgery. Journal of Cataract and Refractive Surgery 2004; 30: 428–32.
7. Richter GM, Choudhury F, Torres M, Azen SP, Varma R. Risk factors for incident cortical, nuclear, posterior subcapsular, and mixed lens opacities: the Los Angeles Latino eye study. Ophthalmology 2012; 119: 2040–7.
8. Kanthan GL, Mitchell P, Burlutsky G, Wang JJ. Fasting blood glucose levels and the long-term incidence and progression of cataract: the Blue Mountains Eye Study. Acta Ophthalmologica 2011; 89: e434–8.
9. Swamy-Mruthinti S, Shaw SM, Zhao HR, Green K, Abraham EC. Evidence of a glycemic threshold for the development of cataracts in diabetic rats. Current Eye Research 1999; 18: 423–9.
10. Datiles MB, 3rd, Kador PF. Type I diabetic cataract. Archives of Ophthalmology 1999; 117: 284–5.
11. Pollreisz A, Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. Journal of Ophthalmology 2010; 2010: 608751.
12. Hong SB, Lee KW, Handa JT, Joo CK. Effect of advanced glycation end products on lens epithelial cells in vitro. Biochemical and Biophysical Research Communications 2000; 275: 53–9.
13. Peppa M, Uribarri J, Vlassara H. The role of advanced glycation end products in the development of atherosclerosis. Current Diabetes Reports 2004; 4: 31–6.
14. Nagaraj RH, Linetsky M, Stitt AW. The pathogenic role of Maillard reaction in the aging eye. Amino Acids 2012; 42: 1205–20.
15. Haddad NM, Sun JK, Abujaber S, Schlossman DK, Silva PS. Cataract surgery and its complications in diabetic patients. Seminars in Ophthalmology 2014; 29: 329–37.
16. Edwards MG, Schachat AP, Bressler SB, Bressler NM. Outcome of cataract operations performed to permit diagnosis, to determine eligibility for laser therapy, or to perform laser therapy of retinal disorders. American Journal of Ophthalmology 1994; 118: 440–4.
17. Mochizuki Y, Kubota T, Hata Y, et al. Surgical results of combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation. European Journal of Ophthalmology 2006; 16: 279–86.
18. Lahey JM, Francis RR, Kearney JJ. Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases. Ophthalmology 2003; 110: 1335–9.
19. Jun Z, Pavlovic S, Jacobi KW. Results of combined vitreoretinal surgery and phacoemulsification with intraocular lens implantation. Clinical & Experimental Ophthalmology 2001; 29: 307–11.
20. Diolaiuti S, Senn P, Schmid MK, Job O, Maloca P, Schipper I. Combined pars plana vitrectomy and phacoemulsification with intraocular lens implantation in severe proliferative diabetic retinopathy. Ophthalmic Surgery, Lasers and Imaging Retina 2006; 37: 468–74.
21. Senn P, Schipper I, Perren B. Combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in the capsular bag: a comparison to vitrectomy and subsequent cataract surgery as a two-step procedure. Ophthalmic Surgery and Lasers 1995; 26: 420–8.
22. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
23. Henricsson M, Nilsson A, Groop L, Heijl A, Janzon L. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control. Acta Ophthalmologica Scandinavica 1996; 74: 523–7.
24. Kodama T, Hayasaka S, Setogawa T. Plasma glucose levels, postoperative complications, and progression of retinopathy in diabetic patients undergoing intraocular lens implantation. Graefe’s Archive for Clinical and Experimental Ophthalmology 1993; 231: 439–43.
25. Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Survey of Ophthalmology 2014; 59: 627–35.
26. Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. American Journal of Ophthalmology 2015; 159: 498–504.
27. Karavanaki K, Davies AG, Hunt LP, Morgan MH, Baum JD. Pupil size in diabetes. Archives of Disease in Childhood 1994; 71: 511–5.
28. Lei HL, Yang KJ, Sun CC, et al. Obtained mydriasis in long-term type 2 diabetic patients. Journal of Ocular Pharmacology and Therapeutics 2011; 27: 599–602.
29. Sadiq SA, Chatterjee A, Vernon SA. Progression of diabetic retinopathy and rubeotic glaucoma following cataract surgery. Eye 1995; 9 (Pt 6): 728–38.
30. Esmaeelpour M, Povazay B, Hermann B, et al. Three-dimensional 1060-nm OCT: choroidal thickness maps in normal subjects and improved posterior segment visualization in cataract patients. Investigative Ophthalmology & Visual Science 2010; 51: 5260–6.
31. Saini JS, Khandalavla B. Corneal epithelial fragility in diabetes mellitus. Canadian Journal of Ophthalmology 1995; 30: 142–6.
32. Chung H, Tolentino FI, Cajita VN, Acosta J, Refojo MF. Reevaluation of corneal complications after closed vitrectomy. Archives of Ophthalmology 1988; 106: 916–9.
33. Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Transactions of the American Ophthalmological Society 1981; 79: 180–99.
34. Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Akagi Y. Corneal changes after small-incision cataract surgery in patients with diabetes mellitus. Archives of Ophthalmology 2004; 122: 966–9.
35. Takamura Y, Kubo E, Akagi Y. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery. Ophthalmology 2009; 116: 1151–7.
36. Kato S, Oshika T, Numaga J, et al. Anterior capsular contraction after cataract surgery in eyes of diabetic patients. British Journal of Ophthalmology 2001; 85: 21–3.
37. Corbett MC, Richards AB. Intraocular adrenaline maintains mydriasis during cataract surgery. British Journal of Ophthalmology 1994; 78: 95–8.
38. Liou SW, Yang CY. The effect of intracameral adrenaline infusion on pupil size, pulse rate, and blood pressure during phacoemulsification. Journal of Ocular Pharmacology and Therapeutics 1998; 14: 357–61.
39. Mirza SA, Alexandridou A, Marshall T, Stavrou P. Surgically induced miosis during phacoemulsification in patients with diabetes mellitus. Eye 2003; 17: 194–9.
40. Zaczek A, Zetterstrom C. Cataract surgery and pupil size in patients with diabetes mellitus. Acta Ophthalmologica Scandinavica 1997; 75: 429–32.
41. Mittra RA, Borrillo JL, Dev S, Mieler WF, Koenig SB. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Archives of Ophthalmology 2000; 118: 912–7.
42. Zare M, Javadi MA, Einollahi B, Baradaran-Rafii AR, Feizi S, Kiavash V. Risk factors for posterior capsule rupture and vitreous loss during phacoemulsification. Journal of Ophthalmic & Vision Research 2009; 4: 208–12.
43. Hashemi H, Mohammadpour M, Jabbarvand M, Nezamdoost Z, Ghadimi H. Incidence of and risk factors for vitreous loss in resident-performed phacoemulsification surgery. Journal of Cataract and Refractive Surgery 2013; 39: 1377–82.
44. Narendran N, Jaycock P, Johnston RL, et al. The Cataract National Dataset electronic multicentre audit of 55,567 operations: risk stratification for posterior capsule rupture and vitreous loss. Eye 2009; 23: 31–7.
45. McCuen BW, 2nd, Klombers L. The choice of posterior chamber intraocular lens style in patients with diabetic retinopathy. Archives of Ophthalmology 1990; 108: 1376–7.
46. Kusaka S, Kodama T, Ohashi Y. Condensation of silicone oil on the posterior surface of a silicone intraocular lens during vitrectomy. American Journal of Ophthalmology 1996; 121: 574–5.
47. Apple DJ, Federman JL, Krolicki TJ, et al. Irreversible silicone oil adhesion to silicone intraocular lenses. A clinicopathologic analysis. Ophthalmology 1996; 103: 1555–61; discussion 61–2.
48. Ostri C, Lux A, Lund-Andersen H, la Cour M. Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: a 10-year follow-up study. Acta Ophthalmologica 2014; 92: 571–6.
49. Gupta B, Wong R, Sivaprasad S, Williamson TH. Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice. Eye 2012; 26: 576–82.
50. Shousha MA, Yoo SH. Cataract surgery after pars plana vitrectomy. Current Opinion in Ophthalmology 2010; 21: 45–9.
51. Braunstein RE, Airiani S. Cataract surgery results after pars plana vitrectomy. Current Opinion in Ophthalmology 2003; 14: 150–4.
52. Nahra Saad D, Castilla Cespedes M, Martinez Palmer A, Pazos Lopez M. Phacoemulsification and lens-iris diaphragm retropulsion syndrome. Ophthalmic Surgery, Lasers & Imaging 2005; 36: 512–3.
53. Krupsky S, Zalish M, Oliver M, Pollack A. Anterior segment complications in diabetic patients following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Ophthalmic Surgery 1991; 22: 526–30.
54. Ionides A, Dowler JG, Hykin PG, Rosen PH, Hamilton AM. Posterior capsule opacification following diabetic extracapsular cataract extraction. Eye 1994; 8 (Pt 5): 535–7.
55. Ruiz RS, Saatci OA. Posterior chamber intraocular lens implantation in eyes with inactive and active proliferative diabetic retinopathy. American Journal of Ophthalmology 1991; 111: 158–62.
56. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 2007; 114: 881–9.
57. Minckler D, Astorino A, Hamilton AM. Cataract surgery in patients with diabetes. Ophthalmology 1998; 105: 949–50.
58. Pande MV, Spalton DJ, Kerr-Muir MG, Marshall J. Postoperative inflammatory response to phacoemulsification and extracapsular cataract surgery: aqueous flare and cells. Journal of Cataract and Refractive Surgery 1996; 22 Suppl 1: 770–4.
59. Liu Y, Luo L, He M, Liu X. Disorders of the blood-aqueous barrier after phacoemulsification in diabetic patients. Eye 2004; 18: 900–4.
60. Oshika T, Kato S, Funatsu H. Quantitative assessment of aqueous flare intensity in diabetes. Graefe’s Archive for Clinical and Experimental Ophthalmology 1989; 227: 518–20.
61. Takamura Y, Tomomatsu T, Arimura S, et al. Anterior capsule contraction and flare intensity in the early stages after cataract surgery in eyes with diabetic retinopathy. Journal of Cataract and Refractive Surgery 2013; 39: 716–21.
62. Poliner LS, Christianson DJ, Escoffery RF, Kolker AE, Gordon ME. Neovascular glaucoma after intracapsular and extracapsular cataract extraction in diabetic patients. American Journal of Ophthalmology 1985; 100: 637–43.
63. Aiello LM, Wand M, Liang G. Neovascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetes mellitus. Ophthalmology 1983; 90: 814–20.
64. Pollack A, Dotan S, Oliver M. Progression of diabetic retinopathy after cataract extraction. The British Journal of Ophthalmology 1991; 75: 547–51.
65. Jaffe GJ, Burton TC. Progression of nonproliferative diabetic retinopathy following cataract extraction. Archives of Ophthalmology 1988; 106: 745–9.
66. Benson WE, Brown GC, Tasman W, McNamara JA, Vander JF. Extracapsular cataract extraction with placement of a posterior chamber lens in patients with diabetic retinopathy. Ophthalmology 1993; 100: 730–8.
67. Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefe’s Archive for Clinical and Experimental Ophthalmology 2002; 240: 735–8.
68. Romero-Aroca P, Fernandez-Ballart J, Almena-Garcia M, Mendez-Marin I, Salvat-Serra M, Buil-Calvo JA. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study. Journal of Cataract and Refractive Surgery 2006; 32: 1438–44.
69. Squirrell D, Bhola R, Bush J, Winder S, Talbot JF. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. British Journal of Ophthalmology 2002; 86: 565–71.
70. Hong T, Mitchell P, de Loryn T, Rochtchina E, Cugati S, Wang JJ. Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery. Ophthalmology 2009; 116: 1510–4.
71. Arevalo JF, Garcia-Amaris RA, Roca JA, et al. Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group. Journal of Cataract and Refractive Surgery 2007; 33: 2098–105.
72. Guo S, Patel S, Baumrind B, et al. Management of pseudophakic cystoid macular edema. Survey of Ophthalmology 2015; 60: 123–37.
73. Barone A, Prascina F, Russo V, et al. Successful treatment of pseudophakic cystoid macular edema with intravitreal bevacizumab. Journal of Cataract and Refractive Surgery 2008; 34: 1210–2.
74. Baker CW, Almukhtar T, Bressler NM, et al. Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. JAMA Ophthalmology 2013; 131: 870–9.
75. Hatch WV, Cernat G, Wong D, Devenyi R, Bell CM. Risk factors for acute endophthalmitis after cataract surgery: a population-based study. Ophthalmology 2009; 116: 425–30.
76. Friling E, Lundstrom M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. Journal of Cataract and Refractive Surgery 2013; 39: 15–21.
77. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Archives of Ophthalmology 1995; 113: 1479–96.
78. Nam KY, Lee JE, Lee JE, et al. Clinical features of infectious endophthalmitis in South Korea: a five-year multicenter study. BMC Infectious Diseases 2015; 15: 177.
79. Phillips WB, 2nd, Tasman WS. Postoperative endophthalmitis in association with diabetes mellitus. Ophthalmology 1994; 101: 508–18.
80. Lim HW, Shin JW, Cho HY, et al. Endogenous endophthalmitis in the Korean population: a six-year retrospective study. Retina 2014; 34: 592–602.
81. Doft BH, Wisniewski SR, Kelsey SF, Fitzgerald SG. Diabetes and postoperative endophthalmitis in the endophthalmitis vitrectomy study. Archives of Ophthalmology 2001; 119: 650–6.
82. Dev S, Pulido JS, Tessler HH, et al. Progression of diabetic retinopathy after endophthalmitis. Ophthalmology 1999; 106: 774–81.
83. Quintana NE, Allocco AR, Ponce JA, Magurno MG. Non steroidal anti-inflammatory drugs in the prevention of cystoid macular edema after uneventful cataract surgery. Clinical Ophthalmology 2014; 8: 1209–12.